New Jersey Bankruptcy Court

Case number: 2:19-bk-13902 - Immune Pharmaceuticals USA Corporation - New Jersey Bankruptcy Court

Case Information
Case title
Immune Pharmaceuticals USA Corporation
Court
New Jersey (njbke)
Chapter
7
Judge
Vincent F. Papalia
Filed
02/26/2019
Last Filing
10/22/2024
Asset
Yes
Vol
v
Docket Header

JNTADMN




U.S. Bankruptcy Court
District of New Jersey (Newark)
Bankruptcy Petition #: 19-13902-VFP

Assigned to: Judge Vincent F. Papalia
Chapter 11
Voluntary
Asset


Date filed:  02/26/2019
341 meeting:  04/17/2019
Deadline for filing claims:  07/16/2019

Debtor

Immune Pharmaceuticals USA Corporation

1 Bridge Plaza North
Suite 270
Fort Lee, NJ 07024
BERGEN-NJ
Tax ID / EIN: XX-XXXXXXX
represented by
Morris S. Bauer

Norris McLaughlin & Marcus, PA
400 Crossing Boulevard
8th Floor
Bridgewater, NJ 08807
908-252-4345
Email: [email protected]

U.S. Trustee

U.S. Trustee

US Dept of Justice
Office of the US Trustee
One Newark Center Ste 2100
Newark, NJ 07102
(973) 645-3014
 
 

Latest Dockets
Date Filed#Docket Text
09/05/201926Docket Text
Monthly Operating Report for Filing Period July, 2017 filed by Morris S. Bauer on behalf of Immune Pharmaceuticals USA Corporation. (Bauer, Morris) (Entered: 09/05/2019)
09/05/201925Docket Text
Monthly Operating Report for Filing Period June, 2019 filed by Morris S. Bauer on behalf of Immune Pharmaceuticals USA Corporation. (Bauer, Morris) (Entered: 09/05/2019)
09/05/201924Docket Text
Monthly Operating Report for Filing Period May, 2019 filed by Morris S. Bauer on behalf of Immune Pharmaceuticals USA Corporation. (Bauer, Morris) (Entered: 09/05/2019)
09/05/201923Docket Text
Monthly Operating Report for Filing Period April, 2019 filed by Morris S. Bauer on behalf of Immune Pharmaceuticals USA Corporation. (Bauer, Morris) (Entered: 09/05/2019)
09/05/201922Docket Text
Monthly Operating Report for Filing Period February, 2019 filed by Morris S. Bauer on behalf of Immune Pharmaceuticals USA Corporation. (Bauer, Morris) (Entered: 09/05/2019)
05/17/201921Docket Text
BNC Certificate of Notice - Order No. of Notices: 1. Notice Date 05/17/2019. (Admin.) (Entered: 05/18/2019)
05/17/201920Docket Text
Certificate of Service (related document: 18 Order Respecting Amendment to Schedule(s)) filed by Morris S. Bauer on behalf of Immune Pharmaceuticals USA Corporation. (Bauer, Morris) (Entered: 05/17/2019)
05/15/201919Docket Text
Monthly Operating Report for Filing Period March, 2019 filed by Morris S. Bauer on behalf of Immune Pharmaceuticals USA Corporation. (Bauer, Morris) (Entered: 05/15/2019)
05/15/201918Docket Text
Order Respecting Amendment to Schedule(s) (related document: 17 Amended Schedules (Fee Attorney) filed by Debtor Immune Pharmaceuticals USA Corporation). Service of notice of the entry of this order pursuant to Rule 9022 was made on the appropriate parties. See BNC Certificate of Notice. Signed on 5/15/2019. (ntp) (Entered: 05/15/2019)
04/17/2019Docket Text
Receipt of filing fee for Amended Schedules (Fee Attorney)( 19-13902-VFP) [misc,amdsch3a] ( 31.00) Filing Fee. Receipt number A38612611, fee amount $ 31.00. (re: Doc# 17) (U.S. Treasury) (Entered: 04/17/2019)